Daniel H Ahn DO M.S.
Gastrointestinal Cancer, Hematologic Oncology
Senior Associate Consultant, Assistant Professor
Join to view full profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Dr. Ahn is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State UniversityM.S., Clinical Investigation, 2014 - 2016
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2009 - 2011
Texas College of Osteopathic MedicineClass of 2008
Certifications & Licensure
TX State License 2011 - 2028
AZ State License 2016 - 2027
OH State License 2013 - 2017
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification FirstNet (CQM), Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2017
Clinical Trials
- TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2017 Dec 11
- A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma Start of enrollment: 2018 Mar 07
- Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Publications & Presentations
PubMed
- REVERCE II: a phase II trial of regorafenib followed by anti-EGFR therapy versus reverse sequencing in refractory metastatic colorectal cancer.Oluseyi B Abidoye, Fang-Shu Ou, Angela Ulrich, Shaylene McCue, Mohamad B Sonbol
The Oncologist. 2026-10-07 - Germline Cancer Testing in Unselected Patients With Neuroendocrine Neoplasms: A Multicenter Prospective Study.Oluseyi Abidoye, Michael Golafshar, Katie Kunz, Cody Eslinger, Zaid Elsabbagh
Pancreas. 2026-09-01 - Early hypoalbuminemia during zolbetuximab therapy in gastroesophageal adenocarcinoma: a retrospective observational study.Fares Jamal, Cody Eslinger, Abdullah Alsulaiman, Tanios Bekaii-Saab, Hao Xie
Journal of Gastrointestinal Oncology. 2026-08-31
Journal Articles
- Systemic Therapy and Sequencing Options in Advanced Hepatocellular CarcinomaMohamad Bassam Sonbol, Amit Mahipal, Zhaohui Jin, Kabir Mody, Mitesh J Borad, Daniel H Ahn, Tanios Bekaii-Saab, JAMA Oncology
- Targeting the Stroma in Pancreatic CancerDaniel H Ahn, Ramesh K Ramanathan, Annals of Palliative Medicine
Press Mentions
Neoadjuvant Chemotherapy Regimen Extends Survival in Pancreatic CancerJuly 14th, 2022- Cardiff Oncology Announces First Patient Dosed in a Phase 2 Trial of Onvansertib in Combination with Irinotecan and 5-FU in Pancreatic CancerJune 8th, 2021
- Why Cardiff Oncology Stock Is Crashing TodayJanuary 15th, 2021
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: